How does a leading global biopharmaceutical company accelerate the complex, data-intensive process of new drug discovery? You need a cloud infrastructure that offers massive, on-demand computing power and advanced data capabilities. That was the challenge for AstraZeneca, a global science-led biopharmaceutical company. To accelerate the development of life-changing medicines, its R&D center in China needed to overcome the limitations of traditional IT infrastructure, which struggled to provide the high-performance computing (HPC) power required for advanced data analysis and simulations. In partnership with Alibaba Cloud, AstraZeneca built a powerful, cloud-based High-Performance Computing (HPC) platform and a unified data lake. By leveraging a suite of services including Elastic High Performance Computing (E-HPC), Elastic GPU Service, and Object Storage Service (OSS), they created a scalable and robust environment for everything from molecular dynamics simulations to AI-powered drug...